ARCHIVES

Lung Cancer Clinical Trials Cost-Effective Alternative

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

July 30, 2004

Advisors seek support for NCI’s “special authorities” granted in 1971.

July 15, 2005

NCI Offers Informations, Resources, To Industry.

April 6, 2001

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

Prostate Cancer Council Calls For Long-Term Screening Research

September 10, 1993

FDA Hazleton Probe Finds Some Problems; Results Unaffected

April 23, 1976